Abstract
Triclosan (TCS), an antimicrobial agent widely used in consumer and medical products, was complexed with 2-hydroxypropyl-β-cyclodextrin (HPβCD) and methyl-β-cyclodextrin (MβCD). Phase-solubility studies indicated that inclusion complexes of 1:1 stoichiometry were formed and allowed estimation of the associated equilibrium constants and free-energy changes. At the highest cyclodextrin concentrations investigated, an almost 20-fold increase in the apparent water solubility of TCS was determined. Susceptibility tests against Escherichia coli and Staphylococcus aureus showed that the TCS–HPβCD and TCS–MβCD complexes exhibited antibacterial properties higher than those of uncomplexed TCS. The two complexes were also found capable of interfering with cell-to-cell communication mechanisms in the C. violaceum model system relying on N-acylhomoserine lactone autoinducers. The inhibitory activity of TCS increased significantly upon inclusion of the drug in HPβCD or MβCD, with small differences between the two CDs. The results obtained suggest that the investigated complexes could be used for treating infections caused by TCS-susceptible pathogens or for preventing biofilm formation on indwelling medical devices such as catheters, stents and orthopedic implants.
References
Athanassiou G, Michaleas S, Lada-Chitiroglou E, Tsitsa T et al (2003) Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance. J Pharm Pharmacol 55:291–300. doi:10.1211/002235702649
Bhargava S, Agrawal GP (2008) Preparation and characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Curr Drug Deliv 5:1–6. doi:10.2174/156720108783330998
Cadieux PA, Chew BH, Knudsen BE, Dejong K et al (2006) Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model. J Urol 175:2331–2335. doi:10.1016/S0022-5347(06)00252-7
Chiappetta DA, Degrossi J, Teves S, D’Aquino M et al (2008) Triclosan-loaded poloxamine micelles for enhanced antibacterial activity against biofilm. Eur J Pharm Biopharm 69:535–545. doi:10.1016/j.ejpb.2007.11.021
Church D, Elsayed S, Reid O, Winston B et al (2006) Burn wound infections. Clin Microbiol Rev 19:403–434
Del Valle EMM (2004) Cyclodextrins and their uses: a review. Process Biochem 39:1033–1046. doi:10.1016/S0032-9592(03)00258-9
Grosse PY, Bressolle F, Pinguet F (1997) Methyl-β-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin. Cancer Chemother Pharmacol 40:489–494. doi:10.1007/s002800050692
Grove C, Liebenberg W, Du Preez JL, Yang W et al (2003) Improving the aqueous solubility of triclosan by solubilization, complexation and in situ salt formation. J Cosmet Sci 54:537–550
Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108. doi:10.1038/nrmicro821
Jayaraman A, Wood TK (2008) Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. Annu Rev Biomed Eng. 10:145–167. doi:10.1146/annurev.bioeng.10.061807.160536
Jones DS, Andrews GP, Gorman SP (2005) Characterization of crosslinking effects on the physicochemical and drug diffusional properties of cationic hydrogels designed as bioactive urological biomaterials. J Pharm Pharmacol 57:1251–1259. doi:10.1211/jpp.57.10.0003
Jones GL, Muller CT, O’Reilly M, Stickler DJ (2006) Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. J Antimicrob Chemother 57:266–272. doi:10.1093/jac/dki447
Jones RD, Jampani HB, Lee AS (2010) Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 28:184–196. doi:10.1016/S0196-6553(00)90027-0
Knetsch MLW, Koole LH (2011) New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymers 3:340–366. doi:10.3390/polym3010340
Landini P, Antoniani D, Burgess JG, Nijland R (2010) Molecular mechanisms of compounds affecting bacterial biofilm formation. Appl Microbiol Biotechnol 86:813–823. doi:10.1007/s00253-010-2468-8
Landis SJ (2008) Chronic wound infection and antimicrobial use. Adv Skin Wound Care 21:531–540
Lavecchia R, Zuorro A (2009) Experimental study of the inclusion of triclosan in hydroxypropyl-β-cyclodextrins. Chem Eng Trans 17:1083–1088. doi:10.3303/cet0917181
Mavromoustakos T, Papadopoulos A, Theodoropoulos E, Dimitriou C et al (1998) Thermal properties of adamantanol derivative and their β-cyclodextrin complexes in phosphatidylcholine bilayers. Life Sci 62:1901–1910. doi:10.1016/S0024-3205(98)00155-6
McClean KH, Winson MK, Fish L, Taylor A et al (1997) Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology 143:3703–3711
Orlik F, Andersen C, Danelon C, Winterhalter M et al (2003) CymA of Klebsiella oxytoca outer membrane: binding of cyclodextrins and study of the current noise of the open channel. Biophys J 85:876–885. doi:10.1016/S0006-3495(03)74527-5
Paulidou A, Maffeo D, Yannakopoulou K, Mavridis IM (2008) Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivates. Carbohydr Res 343:2634–2640. doi:10.1016/j.carres.2008.06.004
Qian L, Guan Y, Xiao H (2008) Preparation and characterization of inclusion complexes of a cationic β-cyclodextrin polymer with butylparaben or triclosan. Int J Pharm 357:224–251. doi:10.1016/j.ijpharm.2008.01.018
Rasmussen TB, Givskov M (2006) Quorum sensing inhibitors: a bargain of effects. Microbiology 152:895–904. doi:10.1099/mic.0.28601-0
Stewart MJ, Parikh S, Xiao G, Tonge PJ et al (1999) Structural basis and mechanism of enoyl reductase inhibition by triclosan. J Mol Biol 290:859–865. doi:10.1099/mic.0.28601-0
Szejtli J (1998) Introduction and general overview of cyclodextrin chemistry. Chem Rev 98:1743–1753. doi:10.1021/cr970022c
Veiga MD, Merino M, Cirri M, Maestrelli F, Mura P (2005) Comparative study on triclosan interactions in solution and in the solid state with naturally and chemically modified cyclodextrins. J Incl Phenom Macro 53:77–83. doi:10.1007/s10847-005-1047-6
Williams P (2007) Quorum sensing, communication and cross-kingdom signalling in the bacterial world. Microbiology 153:3923–3938. doi:10.1099/mic.0.2007/012856-0
Worthington RJ, Richards JJ, Melander C (2012) Small molecule control of bacterial biofilms. Org Biomol Chem 10:7457–7474. doi:10.1039/c2ob25835h
Yang L, Liu Y, Wu H, Song Z, Høiby N, Molin S, Givskov M (2012) Combating biofilms. FEMS Immunol Med Microbiol 65146–65157. doi:10.1111/j.1574-695X.2011.00858.x
Zuorro A, Fidaleo M, Lavecchia R (2010) Solubility enhancement and antibacterial activity of chloramphenicol included in modified beta-cyclodextrins. Bull Korean Chem Soc 31:3460–3462. doi:10.5012/bkcs.2010.31.11.3460
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fidaleo, M., Zuorro, A. & Lavecchia, R. Enhanced antibacterial and anti-quorum sensing activities of triclosan by complexation with modified β-cyclodextrins. World J Microbiol Biotechnol 29, 1731–1736 (2013). https://doi.org/10.1007/s11274-013-1335-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-013-1335-z